Norway· NO-ID_9736FA96-B9A2-4312-A8D9-69150BC67175
Twinrix Paediatric
A kombinationen (hepatitis a + hepatitis b) product containing aluminium phosphate, hepatitis a virus (inactivated ) adsorbed on aluminium hydroxide hydrated produced on human diploid (mrc-5) cells, hepatitis b surface antigen (rdna) adsorbed on aluminium phosphate [produced in s. cerevisae cells by rdna], algeldrate, registered in Norway by GlaxoSmithKline. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Kombinationen (hepatitis a + hepatitis b) is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BC20 (kombinationen (hepatitis a + hepatitis b)), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Kombinationen (hepatitis a + hepatitis b) · ATC J07BC20
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FEST (Norway)- Active substance
- Aluminium Phosphate, Hepatitis A Virus (Inactivated ) Adsorbed On Aluminium Hydroxide Hydrated Produced On Human Diploid (Mrc-5) Cells, Hepatitis B Surface Antigen (Rdna) Adsorbed On Aluminium Phosphate [produced In S. Cerevisae Cells By Rdna], Algeldrate
- Manufacturer
- GlaxoSmithKline
- Country
- Norway (NO)
- ATC code
- J07BC20
- ATC class
- Kombinationen (Hepatitis A + Hepatitis B)
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_9736FA96-B9A2-4312-A8D9-69150BC67175
- no_varenummer1435110.5NOK 446.9
- gtin5054626050135
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BC20
Kombinationen (hepatitis a + hepatitis b), as other registers publish it.
- IcelandAmbirixGlaxoSmithKline Biologicals S.A.*
- DenmarkAmbirixGlaxoSmithKline Biologicals S.A.
- BelgiumAmbirixGlaxoSmithKline Biologicals
- PolandAmbirixGlaxoSmithKline Biologicals S.A.
- FinlandAmbirixGlaxoSmithKline Biologicals S.A.
- CzechiaAMBIRIXGlaxoSmithKline Biologicals S.A., Rixensart
- CzechiaAMBIRIXGlaxoSmithKline Biologicals S.A., Rixensart
- CzechiaAMBIRIXGlaxoSmithKline Biologicals S.A., Rixensart
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9a4ceeda-589c-46b6-abdf-490d7fe50480 GET /v1/drugs/9a4ceeda-589c-46b6-abdf-490d7fe50480?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, suspensjon i ferdigfylt sprøyte",
"source": "fest",
"status": "A",
"atc_name": "Kombinasjoner",
"merkevare_id": "ID_9736FA96-B9A2-4312-A8D9-69150BC67175",
"name_form_strength": "Twinrix Paediatric inj væske, susp 360 ELISA E/0,5 ml/10 mikrog/0,5 ml",
"prescription_group": "C"
}See everything about kombinationen (hepatitis a + hepatitis b).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.